Charles Schwab Investment Management »

Mersana Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $715k 308k 2.32
2023-09-30 $374k 294k 1.27
2023-06-30 $2.7M 821k 3.29
2023-03-31 $3.0M 730k 4.11
2022-12-31 $3.9M 671k 5.86
2022-09-30 $4.4M 644k 6.76
2022-06-30 $3.0M 656k 4.62
2022-03-31 $1.9M 465k 3.99
2021-12-31 $3.0M 488k 6.22
2021-09-30 $4.5M 482k 9.43
2021-06-30 $5.6M 413k 13.58
2021-03-31 $6.0M 370k 16.18
2020-12-31 $9.5M 358k 26.61
2020-09-30 $6.6M 354k 18.62
2020-06-30 $2.8M 119k 23.41
2020-03-31 $502k 86k 5.83
2019-12-31 $488k 85k 5.74
2019-09-30 $135k 85k 1.59
2019-06-30 $345k 85k 4.06
2019-03-31 $184k 35k 5.28
2018-12-31 $100k 25k 4.08
2018-09-30 $281k 28k 10.00
2018-06-30 $438k 25k 17.88
2018-03-31 $321k 20k 15.81